In addition, our recent study showed that omentin, but not adiponectin, was positively associated with vascular endothelial function in high CVD risk subgroups of T2D patients [16], suggesting a dominant role of omentin, rather than adiponectin, against endothelial dysfunction in patients at high CVD risk status. This evidence concerns the gene ITLN1 and endothelial dysfunction.